Поисковый запрос: (<.>A=Steinman, Lawrence$<.>) |
Общее количество найденных документов : 70
Показаны документы с 1 по 20
|
|
1.
| Steinman DNA vaccination for induction of suppressive T cell response
|
2.
| Steinman T-cell receptor varible transcripts as disease related markers
|
3.
| Gijbels Treatment of central nervous system inflammatory disease with matrix metalloprotease inhibitors
|
4.
| Steinman DNA vaccination for treatment of autoimmune disease
|
5.
| Steinman Method and compositions for treating diseases mediated by transglutaminase activity
|
6.
| Steinman DNA vaccination for induction of suppressive T cell response
|
7.
| Optimization of current and future therapy for autoimmune diseases // Nature Med., 2012. Vol. 18, N 1.-С.59-65
|
8.
| Steinman The discovery of natalizumab, a potent therapeutic for multiple sclerosis // J. Cell Biol., 2012. Vol. 199, N 3.-С.413-416
|
9.
| Tyrosine kinase inhibitors ameliorate autoimmune encephalomyelitis in a mouse model of multiple sclerosis // J. Clin. Immunol., 2011. Vol. 31, N 6.-С.1010-1020
|
10.
| Steinman Inverse vaccination to silence immunity to myelin in multiple sclerosis // Can. J. Neurol. Sci., 2010. Vol. 37, прил. 2.-С.49-58
|
11.
| HMG-CoA reductase inhibition causes increased necrosis and apoptosis in an in vivo mouse glioblastoma multiforme model // Anticancer Res., 2009. Vol. 29, N 12.-С.4901-4908
|
12.
| Regulation of different inflammatory diseases by impacting the mevalonate pathway // Immunology, 2009. Vol. 127, N 2.-С.18-25
|
13.
| HMG-CoA reductase inhibition causes increased necrosis and apoptosis in an in vivo mouse glioblastoma multiforme model // Anticancer Res., 2009. Vol. 29, N 12.-С.4901-4908
|
14.
| HMG-CoA reductase inhibition causes increased necrosis and apoptosis in an in vivo mouse glioblastoma multiforme model // Anticancer Res., 2009. Vol. 29, N 12.-С.4901-4908
|
15.
| Differential regulation of chemokines by IL-17 in colonic epithelial cells // J. Immunol., 2008. Vol. 181, N 9.-С.6536-6545
|
16.
| A key regulatory role for histamine in experimental autoimmune encephalomyelitis: Disease exacerbation in histidine decarboxylase-deficient mice // J. Immunol., 2006. Vol. 176, N 1.-С.17-26
|
17.
| Treatment of autoimmune neuroinflammation with a synthetic tryptophan metabolite // Science, 2005. Vol. 310, N 5749.-С.850-855
|
18.
| Immunity to the extracellular domain of nogo-A modulates experimental autoimmune encephalomyelitis // J. Immunol., 2004. Vol. 173, N 11.-С.6981-6992
|
19.
| The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease // Science, 2001. Vol. 294, N 5547.-С.1731-1735
|
20.
| Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial // Nature Med., 2000. Vol. 6, N 10.-С.1076-1082
|
&uf('+1W2226#',v2226), ?>
|
|